News for Spero Therapeutics Stock (SPRO)

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

PRNewsWire • 07/13/22

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spero Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SPRO

PRNewsWire • 07/13/22

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 07/13/22

ROSEN, A Leading Law Firm, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

Newsfile Corp • 07/11/22

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 07/11/22

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 07/08/22

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 07/05/22

SPRO INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

PRNewsWire • 07/04/22

Spero Class Action Complaint Filed: Johnson Fistel, Globally Recognized Law Firm Encourages Shareholders to Submit Their Losses

Newsfile Corp • 07/02/22

ROSEN, A Top Ranked Law Firm, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

Newsfile Corp • 06/29/22

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 06/29/22

ROSEN, LEADING INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

PRNewsWire • 06/28/22

Spero Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Tebipenem HBr New Drug Application

GlobeNewsWire • 06/27/22

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

Newsfile Corp • 06/26/22

ROSEN, Top Ranked Investor Counsel, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

Newsfile Corp • 06/25/22

SPRO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 25, 2022 in the Class Action Filed on Behalf of Spero Therapeutics, Inc. Limited Shareholders

Newsfile Corp • 06/21/22

SPRO INVESTOR NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

PRNewsWire • 06/20/22

ROSEN, A LEADING LAW FIRM, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

Newsfile Corp • 06/16/22

Spero Therapeutics, Inc. Investor News: Robbins LLP is Investigating Spero Therapeutics, Inc. (SPRO) on Behalf of Shareholders

Business Wire • 06/16/22

ROSEN, Top Ranked Investor Counsel, Encourages Spero Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

Newsfile Corp • 06/14/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

PRNewsWire • 06/11/22

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)

Business Wire • 06/09/22

Spero Therapeutics, Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Spero Therapeutics, Inc

PRNewsWire • 06/09/22

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)

Business Wire • 06/08/22

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Spero Therapeutics, Inc. (SPRO) Investors

Business Wire • 06/07/22